CU Ventures

What CU Ventures does

CU Ventures, Inc. is a non-profit 501(c)(3) investment initiative principally affiliated with the Concordia University System, initially established at Concordia University Wisconsin and headquartered at 1200 W. Sierra Lane, Suite B, Mequon, Wisconsin. Its core offering is the Concordia Angel Network (CAN), an accredited-investor angel group that convenes 3-4 pitch meetings per year, vets companies through a formal due diligence process, and selects 2-3 startups per meeting for presentation and potential pre-seed/seed funding. CU Ventures has disclosed deployment of $1.5M in pre-seed capital across 7 Wisconsin startups and maintains a portfolio of eight companies spanning biotechnology (Amruth Group, Estrigenix, Vivid Microscopy), medical devices (RoddyMedical), sport-tech (Huupe), immersive learning/AR-VR (CSI SIM), digital wellness (Joystik Life), and specialty consumer products (Red Elephant Chocolates).

The organization is led by President Daniel S. Sem, Ph.D., MBA, JD (a Concordia Research Professor of Pharmaceutical Sciences and Director of Technology Transfer, who also coleads Walsh Ventures in Michigan and has co-founded biotech companies including one acquired by Novartis) and Director Curtis C. Gielow, MHA, with Janet Mushall as Business Manager and Executive Assistant. Strategic partnerships span the Concordia University System (flagship), Walsh College (multi-state angel expansion), Bridge to Cures (co-host of the annual Healthcare Innovation Pitch program and CTSI AMPDNR consortium participation), and Concordia University Wisconsin and Concordia University Ann Arbor as campus affiliates.

CU Ventures generates revenue through investment returns from its angel portfolio and operating-asset acquisitions (notably Red Elephant Chocolates, acquired in a private equity transaction), with proceeds directed toward grants and scholarships for Concordia universities. The go-to-market is hybrid: event-driven CAN pitch meetings drive deal flow with accredited angel investors, while community-led programming (bootcamps, pitch competitions, the HIP program) cultivates university-affiliated founders. CU Ventures also runs Walsh Ventures as a Michigan-based angel extension through Dr. Sem. There is no disclosed pricing model and no technology product sold — the function is intermediation between capital (accredited angels) and early-stage U.S. companies sourced through Concordia and Walsh College channels.

Name

CU Ventures

Legal name

CU Ventures, Inc.

Website

https://cuventures.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

CU Ventures is a non-profit 501(c)(3) investment initiative affiliated with the Concordia University System that operates the Concordia Angel Network (CAN), running 3-4 accredited-investor pitch meetings per year and deploying pre-seed/seed capital into U.S. startups sourced from Concordia and Walsh College channels.

Ownership category

akta.pro rank

Product category

Angel Investing

NAICS

Portfolio Management and Investment Advice (523940), Miscellaneous Financial Investment Activities (523999)

SIC

Investment Advice (6282), Services-Management Consulting Services (8742)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

akta.pro secondary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

Keywords

• Angel investing
• Venture capital
• Startup funding
• Seed investments
• Angel network

Headquarters

HQ city

Mequon

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Angel Investment Returns: Returns from investments in portfolio companies through the Concordia Angel Network. CU Ventures generates revenue through investment returns which are used to fund grants and scholarships for the universities.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

CU Ventures operates the Concordia Angel Network (CAN), a U.S.-based angel investment platform that reviews pre-seed and seed-stage startups and selects 2-3 companies per quarterly meeting to present to accredited angel investors. It has invested $1.5M in pre-seed capital across 7 Wisconsin startups in recent years. Investment returns are reinvested into grants and scholarships for Concordia University System affiliates.

Product overview

CU Ventures is a university-affiliated investment initiative that operates as a non-profit 501(c)(3) organization focused on funding pre-seed and seed-stage startups through its Concordia Angel Network (CAN). The core offering is the angel investment network, which facilitates connections between startups seeking funding and accredited investors through periodic pitch events. CU Ventures also maintains a portfolio of eight portfolio companies spanning biotechnology (Amruth Group, Estrigenix, Vivid Microscopy), medical devices (RoddyMedical), sports technology (Huupe), immersive learning (CSI SIM), digital wellness (Joystik Life), and specialty consumer products (Red Elephant Chocolates). The investment initiative supports entrepreneurs by providing venture studio services, economic development support, and angel investment facilitation consistent with free-market and Christian ideals.

Differentiator

Problem solved

Functional benefit

Products and services

• Concordia Angel Network (CAN) An affiliate angel investment network that connects U.S.-based startups with accredited investors through 3-4 periodic pitch meetings per year, facilitating pre-seed and seed funding. Companies are vetted through a formal due diligence process before being selected to present, with 2-3 companies chosen per meeting.

Quantifiable outcome

• $1.5M invested in 7 Wisconsin startups through the Concordia Angel Network

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

• Concordia University SystemflagshipStrategic or Co-development PartnerCU Ventures is a non-profit 501c3 organization principally affiliated with the multiple universities of the Concordia University System, established initially at Concordia University Wisconsin. The partnership provides access to university talent, research, and tech transfer opportunities.
• Bridge to Cures, Inc.coreStrategic or Co-development PartnerNonprofit co-hosted by CU Ventures President Dan Sem as CEO, cohosting the annual Healthcare Innovation Pitch (HIP) program with consortium participation in CTSI AMPDNR program.
• Walsh CollegecoreStrategic or Co-development PartnerDr. Daniel Sem serves as Professor of Management and Marketing at Walsh College and coleads the angel group through CU Ventures and Walsh Ventures, providing venture studio and economic development support.
• CTSI AMPDNR (Clinical and Translational Science Institute)minorStrategic or Co-development PartnerAccelerating Medical Product Development through Networked Resources program consortium in which Bridge to Cures participates, involving multiple tech-transfer offices.
• Concordia University WisconsincoreStrategic or Co-development PartnerInitial founding location of CU Ventures and partner in research with portfolio companies like Joystik Life. Students and alumni from this university participate in CU Ventures programs.
• Concordia University Ann ArborminorStrategic or Co-development PartnerFormer founding location of CU Ventures Director Curtis Gielow as Campus Chief Executive, now part of the Concordia University System affiliation.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• MassChallenge: Global nonprofit accelerator that runs cohort programs for early-stage startups, providing mentorship and connecting founders to investors. Overlaps with CU Ventures on the venture-studio/community-event GTM, but operates at dramatically larger scale across multiple sectors and geographies.
• BioGenerator: St. Louis-based investor and startup builder specializing in bioscience and healthcare companies, including those sourced from regional research institutions. Comparable because of CU Ventures' healthcare/biotech tilt via HIP and CTSI AMPDNR, though BioGenerator operates at materially larger scale and broader sector breadth.

Direct peers

• gener8tor: Milwaukee-headquartered accelerator and venture fund that runs cohort-based programs and invests in early-stage startups, frequently with Wisconsin/Midwest roots. Highly comparable GTM (cohort pitch meetings, accredited investor networks) and stage focus to the Concordia Angel Network.
• Wisconsin Alumni Research Foundation (WARF): UW-Madison's nonprofit patenting and licensing arm that invests in and supports spinout companies from university research. Like CU Ventures, it is a university-affiliated non-profit that channels research IP into investable ventures, though WARF operates at materially larger scale.
• Madison Angels: Wisconsin-based angel investor network that pools accredited investors to fund early-stage companies. Direct competitor for the same Wisconsin deal-flow and the same accredited angel LP base that CU Ventures serves.
• Northwestern University Innovation and New Ventures Office (INVO): Northwestern's tech-transfer and startup support office that commercializes faculty/student research and engages the regional investor community. Directly comparable mission and structure to CU Ventures' tech-transfer aligned investment approach.
• WashU Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship: Washington University in St. Louis hub that runs student/alumni pitch competitions, bootcamps, and connects founders to investor networks — a university-affiliated entrepreneurship platform with the same community-led GTM as CU Ventures.
• Golden Angels Investors: One of the largest angel networks in the U.S., based in the Midwest, that facilitates pitch meetings and due diligence for accredited investors investing in early-stage companies. Closely mirrors the Concordia Angel Network model at greater scale and broader geographic reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/cu-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CU Ventures